The inhibitory role of LINC00261 in prostate cancer cell proliferation, migration, as well as angiogenesis, has been demonstrated in relation to the mechanism concerning the GATA6‐mediated DKK3.34 This evidence concerns the gene GATA6 and prostate carcinoma.